We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+6.94%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$54.2B
AUM Growth
+$30.1B
Cap. Flow
+$28.6B
Cap. Flow %
52.81%
Top 10 Hldgs %
15.56%
Holding
4,600
New
1,635
Increased
1,281
Reduced
635
Closed
782

Sector Composition

Rank Sector Weight
1 Technology 17.77%
2 Healthcare 17.47%
3 Financials 15.58%
4 Consumer Discretionary 12.3%
5 Communication Services 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRD.A icon
3526
Crawford & Co Class A
CRD.A
$545M
$30K ﹤0.01%
+4,167
New +$34.4K
FBIO icon
3527
Fortress Biotech
FBIO
$109M
$30K ﹤0.01%
+810
New +$36.1K
KEN icon
3528
Kenon Holdings
KEN
$3.64B
$30K ﹤0.01%
586
-16,757
-97% -$727K
PR
3529
Permian Resources
PR
$17B
$30K ﹤0.01%
+5,162
New +$35.2K
SOS
3530
SOS Limited
SOS
$18M
$30K ﹤0.01%
+50
New +$61.1K
GSQB
3531
DELISTED
G Squared Ascend II Inc.
GSQB
$30K ﹤0.01%
+3,135
New +$30.7K
ANVS icon
3532
Annovis Bio
ANVS
$71M
$29K ﹤0.01%
+1,679
New +$43.3K
BLRX
3533
BioLineRX
BLRX
$12.3M
$29K ﹤0.01%
+363
New +$37.8K
YRD
3534
Yiren Digital
YRD
$103M
$29K ﹤0.01%
10,087
-53,892
-84% -$173K
CPK icon
3535
Chesapeake Utilities
CPK
$3.26B
$28K ﹤0.01%
+198
New +$26.3K
XPH icon
3536
State Street SPDR S&P Pharmaceuticals ETF
XPH
$480M
$28K ﹤0.01%
+602
New +$28.5K
OFLX icon
3537
Omega Flex
OFLX
$305M
$27K ﹤0.01%
+219
New +$29.1K
BIOL
3538
DELISTED
Biolase, Inc.
BIOL
$27K ﹤0.01%
29
-272
-90% -$343K
PNT
3539
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$27K ﹤0.01%
+4,870
New +$36.5K
CABA icon
3540
Cabaletta Bio
CABA
$444M
$26K ﹤0.01%
6,944
-57,211
-89% -$610K
CWST icon
3541
Casella Waste Systems
CWST
$5.68B
$26K ﹤0.01%
+300
New +$25.1K
JAMF
3542
DELISTED
Jamf
JAMF
$26K ﹤0.01%
+669
New +$25.9K
RVMD icon
3543
Revolution Medicines
RVMD
$40B
$26K ﹤0.01%
+1,029
New +$29K
SANW
3544
DELISTED
S&W Seed Co
SANW
$26K ﹤0.01%
+504
New +$29.4K
TESS
3545
DELISTED
Tessco Technologies Inc
TESS
$26K ﹤0.01%
+4,195
New +$25.1K
TWTR
3546
PUT
DELISTED
Twitter, Inc.
TWTR
$26K ﹤0.01%
+600
New +$31.2K
KMB icon
3547
Kimberly-Clark
KMB
$37B
$25K ﹤0.01%
+175
New +$23.6K
MARK
3548
DELISTED
Remark Holdings, Inc.
MARK
$25K ﹤0.01%
+2,489
New +$32.4K
IFX
3549
DELISTED
INFINEON TECH AG ADS(REP1 ORD)
IFX
$25K ﹤0.01%
+520
New +$25K
IMUX icon
3550
Immunic
IMUX
$188M
$24K ﹤0.01%
+243
New +$21.9K

Similar funds

Marshall Wace's Q4 2021 Portfolio in Review

As of Q4 2021, Marshall Wace held 4,600 positions worth $54.2B, up 125% from $24.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace deployed $28.6B of net new capital in Q4 2021, opening 1,635 new positions and adding to 1,281 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Accenture, an estimated $192M trimmed.

  • Marshall Wace's largest Q4 2021 buy was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.
  • Marshall Wace added most to Microsoft in Q4 2021, an estimated $1.08B increase.
  • Marshall Wace's biggest Q4 2021 reduction was Accenture, cutting an estimated $192M.
  • Marshall Wace fully exited Sabre in Q4 2021, selling an estimated $44.1M.
  • Marshall Wace's ten largest holdings make up 16% of its $54.2B portfolio in Q4 2021.
  • Marshall Wace opened 1,635 new positions and closed 782 in Q4 2021.
  • Marshall Wace's portfolio value rose 125% quarter-over-quarter to $54.2B.

Based on Marshall Wace's 13F filing for Q4 2021, filed 14 Feb 2022.